47 minutes ago

Hims & Hers Health, Inc. (HIMS) Stock: Peptides+ Launch Expands Healthcare Services

TLDR HIMS stock falls 2.93% to $17.04 despite the launch of its Peptides+ service. Peptides+ debuts with five treatments guided by licensed medical providers. Hims & Hers adds cellular health services to its growing telehealth platform. Care+ offers twice-yearly lab tests and ongoing support from medical teams. Hims & Hers plans to add BPC-157 and [...]

The post Hims & Hers Health, Inc. (HIMS) Stock: Peptides+ Launch Expands Healthcare Services appeared first on Blockonomi.

Source: Blockonomi →